The iShares Biotechnology ETF (IBB) experienced a significant outflow of approximately $206.7 million, reflecting a 2.4% week-over-week decrease in shares outstanding, dropping from 50.1 million to 48.9 million units. The change was observed as of the latest trading session, with key holdings such as Alnylam Pharmaceuticals (ALNY) down 0.9%, Insmed (INSM) down 0.5%, and argenx SE (ARGX) down 1.2%.
IBB’s 52-week price range shows a low of $107.43 and a high of $179.64, with the latest trading price at $171.83, positioned just below its 200-day moving average. This information provides insight into the ETF’s recent performance trends amid notable outflows.
